Transcat, Inc. — Fiscal Second Quarter 2027 Earnings Summary

Transcat, Inc. reported fiscal second quarter 2027 results with total revenue increasing 18% to $97.1 million, driven by a 23% rise in service revenue to $64.8 million and a 10% increase in distribution revenue to $32.3 million. The company achieved a 220 basis point expansion in service gross margins to 34% and reported a 23% increase in adjusted EBITDA to $14.9 million. Net income for the quarter grew 90.1% to $2.4 million, while diluted earnings per share rose to $0.25. Management raised its full-year service organic revenue growth outlook to the low double digits, citing strong momentum in regulated end markets and the recent acquisition of Southeastern Biomedical.